FeesSafety
Pluang+

SI-BONE Q3 revenue rises 15% to $55.7M as new spinal implant expands $5B market opportunity

Company Fundamentals
22 Nov 2026, 23:57 WIB
The Motley Fool
View Source
Bullish
SI-BONE Q3 revenue rises 15% to $55.7M as new spinal implant expands $5B market opportunity

SI-BONE reported a 15% increase in worldwide revenue to $55.7 million in Q3 2026, driven by growing adoption of its surgical implants. The FDA-cleared iFuse Granite Onyx device targets spinal fusion failures, expanding the company's addressable market to about $5 billion. Higher Medicare reimbursement rates for complex spinal surgeries are expected to boost hospital adoption. The active physician base also grew 16% to 1,770 doctors, enhancing commercial reach and supporting future growth prospects.

SI-BONE's recent report highlights its revenue growth and market expansion. For readers following the health sector, here is Pluang's market snapshot as of Nov 23, 2026 04:31 WIB: out of 150 priced US health stocks, 31 rose and 117 fell. Notable movers include TXG at USD 51.80 with a -9.72% change, TMDX at USD 85.25 down 9.33%, and BRKR at USD 56.47 down 9.07%.

More News

Gorilla Technology posts record $69.5M Q3 revenue, targets $200M in 2026 amid AI infrastructure growth

Gorilla Technology posts record $69.5M Q3 revenue, targets $200M in 2026 amid AI infrastructure growth

Gorilla Technology reported a record $69.5 million in revenue for Q3 2026, driven by expanding AI infrastructure projects and hardware deliveries. The company reduced unbilled contract assets by over 50%, improving liquidity as it shifts focus from s...

Company Fundamentals
Bullish
24 minutes ago
Berkshire Hathaway holds steady on Apple shares despite 29% price rise and high valuation in 2026.

Berkshire Hathaway holds steady on Apple shares despite 29% price rise and high valuation in 2026.

Berkshire Hathaway has not sold any Apple shares in 2026, even as Apple's stock price rose 29% and its price-to-earnings ratio neared 40, indicating less concern about valuation. This decision reflects confidence in Apple's strong business fundamenta...

Market News
Bullish
28 minutes ago
US invests $1.6B to build domestic rare-earth supply chain with USA Rare Earth leading Texas mine development.

US invests $1.6B to build domestic rare-earth supply chain with USA Rare Earth leading Texas mine development.

The U.S. government is investing $1.6 billion to develop a domestic rare-earth supply chain, aiming to reduce reliance on China. USA Rare Earth is a key player, using the funds to build out mining and processing capabilities, including developing the...

Market News
Bullish
33 minutes ago
Alamar Biosciences raises 2026 revenue forecast to $121-$123M, driven by biopharma demand and clinical diagnostics expansion.

Alamar Biosciences raises 2026 revenue forecast to $121-$123M, driven by biopharma demand and clinical diagnostics expansion.

Alamar Biosciences increased its full-year 2026 revenue guidance to $121-$123 million, fueled by strong demand for consumables from biopharmaceutical clients who now represent 49% of Q3 revenue. The company’s NULISA platform was selected by the U.K. ...

Company Fundamentals
Bullish
33 minutes ago
CeriBell raises 2026 revenue forecast to $115-$117M, boosts hospital accounts and gross margin to 90%.

CeriBell raises 2026 revenue forecast to $115-$117M, boosts hospital accounts and gross margin to 90%.

CeriBell updated its full-year 2026 revenue guidance to $115 million to $117 million, driven by increased usage per hospital account and expansion by 35 new hospital accounts. The company improved its gross margin to 90% from 88% last year, supported...

Company Fundamentals
Bullish
33 minutes ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App